Envejecemos, y ¿El hígado?

Cristobal Betancourt

Métricas obtenidas de Google Analytics a partir de octubre de 2024.

67 vistas totales
67 vistas en el último mes

Resumen


La población mundial de mayores de 75 años ha crecido y conocemos más sobre enfermedades crónicas sistémicas, pero el impacto en el hígado está en una búsqueda creciente ante la luz de nuevas investigaciones. Pretendemos hace una breve visión panorámica sobre los nuevos conocimientos sobre el hígado longevo, un sistema biológico complejo y no escapa del envejecimiento.

 

ESCUCHE EL RESUMEN HANCIENDO CLIC EN EL IDIOMA DE SU PREFERENCIA:

Español
English
Portugués
Japones

Palabras clave


Envejecimiento; Hígado envejecido; Longevidad.

Texto completo:

PDF

Referencias


Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7(1):391.

Tenchov R, Sasso JM, Wang X, Zhou QA. Aging hallmarks and progression of age-related diseases: a landscape view of research advancement. ACS Chem Neurosci. 2024;15(1):1–30.

Franceschi C, Garagnani P, Morsiani C, et al. The continuum of aging and age-related diseases: common mechanisms but different rates. Front Med (Lausanne). 2018;5:61.

Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg. 1990;211:141–145.

Ganguly S, Sakane S, Hokutan K, et al. Aging and aging-related senescence in liver. Semin Liver Dis. 2025;45:549–566.

Georgieva M, Xenodochidis C, Krasteva N. Old age as a risk factor for liver diseases. Exp Gerontol. 2023;184:112334.

Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467–484.

Brooks-Wilson AR. Genetics of healthy aging and longevity. Hum Genet. 2013;132(12):1323–1338.

Chen Y, Geng A, Zhang W, et al. Fight to the bitter end: DNA repair and aging. Ageing Res Rev. 2020;64:101154.

Nebel A, Flachsbart F, Till A, et al. A functional EXO1 promoter variant is associated with prolonged life expectancy in centenarians. Mech Ageing Dev. 2009;130(10):691–699.

Gordon LB, Rothman FG, López-Otín C, Misteli T. Progeria: a paradigm for translational medicine. Cell. 2014;156(3):400–407.

Carrero D, Soria-Valles C, López-Otín C. Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells. Dis Model Mech. 2016;9(7):719–735.

Alexandrov LB, Jones PH, Wedge DC, et al. Clock-like mutational processes in human somatic cells. Nat Genet. 2015;47(12):1402–1407.

Schmucker DL. Age-related changes in liver structure and function: implications for disease? Exp Gerontol. 2005;40(8-9):650–659.

Kim IH, Xu J, Liu X, et al. Aging increases the susceptibility of hepatic inflammation and fibrosis in response to high-fat diet in mice. Age (Dordr). 2016;38(4):291–302.

Wakabayashi H, Nishiyama Y, Ushiyama T, Maeba T, Maeta H. Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. J Surg Res. 2002;106(2):246–253.

Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184–191.

Williams SN, Ding WX. The impact of aging on liver health and the development of liver diseases. Hepatol Commun. 2025;9:e0808.

Warraich UE, Hussain F, Kayani HUR. Aging—oxidative stress, antioxidants and computational modeling. Heliyon. 2020;6:e04107.

Chandrasekaran A, Idelchik M, Melendez JA. Redox control of senescence and age-related disease. Redox Biol. 2017;11:91–102.

Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757–772.

Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18:40–55.

Brenner C. Sirtuins are not conserved longevity genes. Life Metab. 2022;1:122–133.

Zhao L, Cao J, Hu K, He X, Yun D, Tong T, et al. Sirtuins and their biological relevance in aging and age-related diseases. Aging Dis. 2020;11:927–945.

Chen C, Zhou M, Ge Y, Wang X. SIRT1 and aging related signaling pathways. Mech Ageing Dev. 2020;187:111215.

Yuan Y, Cruzat VF, Newsholme P, Cheng J, Chen Y, Lu Y. Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mech Ageing Dev. 2016;155: 10–21.

Adjei-Mosi J, Sun Q, Smithson SB, Shealy GL, Amerineni KD, Liang Z, et al. Age-dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution. Aging Cell. 2023;22:e13811.

Zhang Y, Gong C, Tao L, Zhai J, Huang F, Zhang S. Involvement of SIRT1-mediated aging in liver diseases. Front Cell Dev Biol. 2025;13:1548015.

Herranz D, Muñoz-Martin M, Cañamero M, Mulero F, Martinez-Pastor B, Fernandez-Capetillo O, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. 2010;1:3.

Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24:464–471.

Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, et al. Sirt1 extends life span and delays aging in mice through regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 2013;18:416–430.

Mitchell SJ, Bernier M, Aon MA, Cortassa S, Kim EY, Fang EF, et al. Nicotinamide improves aspects of healthspan, but not lifespan, in mice. Cell Metab. 2018;27:667–676.e4.

Ruiz Torres A. Envejecimiento: causa, mecanismos y regulación. Rev Esp Geriatr Gerontol. 2001;36(Suppl 5):13–19.




DOI: http://dx.doi.org/10.61155/gen.v80i2.816
NUESTROS PATROCINADORES